Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intra‐pleural Fibrinolytic Therapy Versus Placebo, or a Different Fibrinolytic Agent, in the Treatment of Adult Parapneumonic Effusions and Empyema." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437359/all/. Accessed 02 May 2024.
Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437359/all/. Accessed May 2, 2024.
Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437359/all/
Intra‐pleural Fibrinolytic Therapy Versus Placebo, or a Different Fibrinolytic Agent, in the Treatment of Adult Parapneumonic Effusions and Empyema [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437359/all/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
ID - 437359
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437359/all/
DB - Evidence Central
DP - Unbound Medicine
ER -